Optimization of the management of the third stage of labor and early postpartum period in women with uterine leiomyoma

Authors

DOI:

https://doi.org/10.15574/PP.2025.4(104).4549

Keywords:

uterine leiomyoma, labor, third stage of labor, postpartum period, blood loss, uterine involution

Abstract

Aim - to optmize the management of the third stage of labor and the early postpartum period in women with uterine leiomyoma through the implementation of a modified preventive algorithm.

Materials and methods. A prospective study was conducted involving 120 women with term pregnancy and uterine leiomyoma (types 3-5 according to the International Federation of Gynecology and Obstetrics classification with nodules larger than 5 cm). The participants were divided into two groups: Group І - 60 women who received standard management of the third stage of labor and the postpartum period in accordance with the protocols of the Ministry of Health of Ukraine; Group ІІ - 60 women who received the proposed algorithm (intravenous administration of 1 g tranexamic acid during the third stage of labor and remodeling of the lower uterine segment in the early postpartum period). The study compared the following indicators: the volume of blood loss during childbirth and during the early postpartum period, the frequency of postpartum bleeding (more than 500 ml), the dynamics of hemoglobin levels before childbirth and within 5 days after childbirth, and indicators of uterine involution in the postpartum period.

Results. In women of Group 2, a reduction of up to 30% in the mean blood loss was observed, along with a threefold decrease in the incidence of postpartum hemorrhage, significantly higher hemoglobin level in the postpartum period (p<0.05) and faster uterine involution compared to standard management.

Conclusions. The proposed algorithm significantly reduces the frequency and severity of postpartum hemorrhage in women with uterine leiomyoma. The combination of tranexamic acid and lower uterine segment remodeling represents an effective preventive strategy for patients at high obstetric risk. The implementation of this approach allows to increase the effectiveness of primary prevention of obstetric bleeding in women with uterine leiomyoma without the use of uterotonic agents and without the need for other invasive interventions.

The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee. Written informed consent was obtained from all participants.

The authors declare no conflict of interest.

Author Biographies

I.M. Morokhovets, Bogomolets National Medical University, Kyiv

Perinatal Center of Kyiv, Ukraine

D.O. Govsieiev, Bogomolets National Medical University, Kyiv

Perinatal Center of Kyiv, Ukraine

References

Gungorduk K, Asicioğlu O, Yildirim G et al. (2013). Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Am J Perinatol. 30(5): 407-413. https://doi.org/10.1055/s-0032-1326986; PMid:23023559

Jenabi E, Khazaei S, Masoumi. SZ. (2020, Nov The Association between Uterine Leiomyoma and Postpartum Hemorrhage: A Meta-Analysis. Current Women's Health Reviews. 16; 4: 259-264. https://doi.org/10.2174/1573404816999200421101112

Li H, Hu Z, Fan Y et al. (2024). The influence of uterine fibroids on adverse outcomes in pregnant women: a meta-analysis. BMC Pregnancy Childbirth. 24: 345. https://doi.org/10.1186/s12884-024-06545-5; PMid:38710995 PMCid:PMC11071265

Makarenko MM, Govseev DA, Aksenov VB. (2013). Effective technique for bleeding during cesarean section (RENIS II - remodeling of the lower segment of the uterus). Health Woman. (4): 48-49.

Makarenko MV, Hovsieiev DO, Berestovyi VO, Vorona RM, Sokol IV. (2017). Sposib prypynennia krovotechi u porodilli pislia fiziolohichnykh polohiv. Svidotstvo No. u2017 01957 vid 10.11.2017.

Mielke RT, Obermeyer S. (2020, May). The Use of Tranexamic Acid to Prevent Postpartum Hemorrhage. J Midwifery Womens Health. 65(3): 410-416. Epub 2020 May 19. https://doi.org/10.1111/jmwh.13101; PMid:32431098 PMCid:PMC7383973

Mirgharourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, Shirdel M. (2015). The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology. 55: 53-58. https://doi.org/10.1111/ajo.12262; PMid:25688820

MOZ Ukrainy. (2022). Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Fiziolohichni polohy» MOZ Ukrainy. Nakaz Ministerstva okhorony zdorov'ia Ukrainy vid 26 sichnia 2022 roku No. 170.

Novikova N, Hofmeyr GJ, Cluver C. (2015, Jun 16). Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2015(6): CD007872. doi: 10.1002/14651858.CD007872.pub3. Update in: Cochrane Database Syst Rev. 2025 Jan 15; 1: CD007872. https://doi.org/10.1002/14651858.CD007872.pub4; PMid:39812173 PMCid:PMC12043208

Papageorghiou AT, Kihara AB, Dunkley-Bent J et al. (2025). New guidelines for the prevention, diagnosis, and treatment of postpartum haemorrhage: ending the geography of risk. The Lancet Global Health. 13; 11: e1796-e1798. https://doi.org/10.1016/S2214-109X(25)00404-8; PMid:41056964

Published

2025-12-28